Loading company…
Won 23 federal SBIR/STTR research awards from HHS and other federal agencies.
GLYCAN THERAPEUTICS CORPORATION has been awarded 23 US Small Business Innovation Research (SBIR/STTR) contracts totalling $24,774,511 between 2013 and 2024. These are non-dilutive federal research grants, not equity financing. The company is based in RALEIGH, North Carolina.
23 rounds · latest SBIR Phase II award (HHS), Sep 2024
Sign in to see 23 rounds.
Sign inNo investors recorded yet for GLYCAN THERAPEUTICS CORPORATION.
Add an investorGLYCAN THERAPEUTICS CORPORATION has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for GLYCAN THERAPEUTICS CORPORATION.
Add diversity dataSign in to see 6 more people.
Sign in